| Oct 30 |
Investors in Anika Therapeutics (NASDAQ:ANIK) have unfortunately lost 61% over the last five years
|
| Oct 17 |
Anika Announces Third Quarter 2024 Results Conference Call Date
|
| Oct 9 |
Anika Therapeutics Inc (ANIK) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges ...
|
| Aug 11 |
Anika Therapeutics, Inc. 2024 Q2 - Results - Earnings Call Presentation
|
| Aug 11 |
Anika Therapeutics, Inc (ANIK) Q2 2024 Earnings Call Transcript
|
| Aug 10 |
Anika Therapeutics, Inc. (NASDAQ:ANIK) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
|
| Aug 9 |
Anika Therapeutics, Inc. (ANIK): Are Hedge Funds Bullish on This Caligan Partners-Approved Stock?
|
| Aug 8 |
Anika Therapeutics (ANIK) Q2 Earnings Lag Estimates
|
| Aug 8 |
Anika: Q2 Earnings Snapshot
|
| Aug 8 |
Anika Therapeutics Non-GAAP EPS of $0.17 misses by $0.03, revenue of $41.9M beats by $1.13M
|
